Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-016081

Director acquired 8,876 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Mehra Anand · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2020-03-02 Exercise or conversion : show line 1 in the form +8,876 8,876 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-03-02 Grant or award : show line 2 in the form Restricted stock units +8,876 8,876 D
2020-03-02 Exercise or conversion : show line 3 in the form Restricted stock units −8,876 0 D
Loading xslF345X03/doc4.xml…